Evotec and GARDP announce new partnership to discover novel antibiotics

Collaboration explores opportunities to set up antibiotic discovery and development platform and establish a joint pipeline of novel antibiotic assets Discovery efforts will focus on World Health Organisation (“WHO”) priority pathogens

Topics: Corporate, Antibiotic Resistance, Drug Discovery, Gram-negative bacteria, Antibacterial, Evotec, GARDP, WHO Read More

Evotec and Galapagos enter into collaboration in the field of Fibrosis

Collaboration comprises licence agreement for a programme developed by Evotec as well as its drug discovery capabilities Evotec receives undisclosed upfront payment, adn is eligible for potential milestones as well as royalty payments

Topics: Corporate, Drug Discovery, Evotec, Galapagos, Fibrosis, NASH Read More

Evotec receives milestone payment for start of Phase II clinical trial

Evotec's partner, Second Genome, begins a Phase II Clinical trial for NASH with licensed molecule,

Topics: Corporate, Evotec, NASH, Microbiome, Second Genome Read More

Evotec and LEO Pharma form drug discovery alliance targeting dermatological conditions

Identify new leads for innovative targets in the dermatology field The alliance will use Evotec's world leading drug discovery platform

Topics: Corporate, Drug Development, Drug Discovery, Evotec, LEO Pharma, hit identification, Dermatology, Integrated drug discovery Read More

Evotec and Immuneering to collaborate on Artificial Intelligence (“AI”) driven ligand identification for rare hereditary metabolic diseases

Combination of cutting-edge IPSC and AI technologies creates opportunity to discover novel metabolic ligands to accelerate drug discovery in rare metabolic diseases

Topics: Corporate, IPSC, Evotec, metabolic diseases, Immuneering, artificial intelligence Read More

Ferring and Evotec form strategic research alliance in reproductive medicine and women’s health

Ferring accesses Evotec's integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates Evotec is eligible for undisclosed research funding and milestones 

Topics: Corporate, Drug Development, Evotec, Ferring, Reproductive medicine, Women's health, small molecule Read More

Evotec and Celgene expand IPSC collaboration to include additional cell lines

$ 6 M payment to access additional cell lines

Topics: Corporate, Celgene, IPSC, Evotec, Induced pluripotent stem cells Read More

Evotec signs agreement with Sanofi to advance early stage academic research into novel therapeutic candidates

The creation of LAB031 is designed to translate academic research into drug discovery candidates Evotec aims to generate multiple lead candidates for Sanofi over three years across multiple therapeutic categories

Topics: Corporate, Sanofi, Evotec, LAB031, BRIDGE Read More

Evotec publishes DDup 7 – Kidney diseases 2.0

In this 7th DDup issue, we delve into the unique new kidney platforms poised to change the trajectory of kidney disease research and therapeutics development. Evotec has embarked on a novel collaboration model with Kidney Research UK, University of Bristol, University of Cambridge, University of ...

Topics: Corporate, Evotec, DDup, Kidney diseases Read More

Evotec and Almirall enter into research collaboration in the field of dermatological diseases

Collaboration is focused on first-in-class therapies to treat dermatological diseases Collaboration leverages a novel approach to disrupt cell signalling, validated by EVT Innovate

Topics: Corporate, Evotec, Almirall Read More

Most Read

Posts by Topic